Orbit Biomedical
Ambler
About Orbit Biomedical
Orbit Biomedical’s mission is to revolutionize gene and cell therapy treatment by setting a new standard for precise, targeted surgical delivery. Our focus is to transform the accuracy, safety and consistency of delivering therapeutics to patients. Located in Philadelphia, Orbit Biomedical was founded in 2018 with a Series A investment from Syncona, a leading FTSE250 healthcare company focused on investing in and building global leaders in life science.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Funding stage: M&A
- Last round: Seed (Jan 2019)
- Website: orbitsds.com
- Phone: [email protected]
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/orbit-biomedical-1956350 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.